Chemed Corp Stock Price, News & Analysis

Chemed Corporation (NYSE:CHE) will release its fourth quarter financial results for the period ending December 31, 2021, on February 24, 2022, after market close. A conference call to discuss these results is scheduled for February 25, 2022, at 10 a.m. ET, accessible via phone and webcast. Chemed operates VITAS Healthcare, the largest hospice provider, and Roto-Rooter, a leading plumbing service. Forward-looking statements regarding the company's performance highlight inherent risks that could lead to actual results differing materially from projections.

Chemed Corporation (NYSE:CHE) will present at the BofA Securities 2021 Virtual Home Care Conference on December 7, 2021, at 11:00 AM (ET). The presentation will be available via live webcast on the Chemed website, with a replay accessible within 24 hours for 90 days. Headquartered in Cincinnati, Ohio, Chemed operates subsidiaries VITAS Healthcare, the largest end-of-life hospice care provider, and Roto-Rooter, the leading plumbing and drain cleaning service in the U.S.

Chemed Corporation (NYSE:CHE) has authorized an additional $300 million for stock repurchase under its existing program, funded by operational cash and a revolving credit facility. This move aims to enhance shareholder value by reducing the number of outstanding shares, potentially leading to an increase in earnings per share (EPS). Chemed is known for its subsidiaries VITAS Healthcare, the largest hospice care provider, and Roto-Rooter, a leading plumbing service.

Chemed Corporation (NYSE:CHE) has declared a quarterly cash dividend of 36-cents per share, payable on December 6, 2021 to shareholders of record as of November 15, 2021. This dividend matches the amount paid in September 2021 and marks the 202nd consecutive quarterly dividend since the company's inception as a public entity 50 years ago. Chemed operates VITAS Healthcare and Roto-Rooter, leading providers in hospice care and plumbing services, respectively.

Chemed Corporation (NYSE:CHE) will present at the Credit Suisse 30th Annual Virtual Healthcare Conference on November 10, 2021, at 1:00 p.m. ET. The presentation will be available via live webcast on their website, www.chemed.com, with a replay accessible within 24 hours for 90 days. Chemed, headquartered in Cincinnati, Ohio, operates VITAS Healthcare, the largest provider of hospice care, and Roto-Rooter, a leading plumbing service.

Chemed Corporation (NYSE: CHE) reported its Q3 2021 results with mixed performance. Overall revenue rose 2.0% to $539 million. The diluted EPS increased by 9.9% to $4.55, while adjusted diluted EPS rose 4.1% to $5.06. The VITAS segment faced challenges, with net patient revenue declining 5.8% to $317 million, while Roto-Rooter experienced a robust 15.7% revenue growth to $221 million. Adjusted EBITDA for VITAS fell 11.5% to $60.4 million, but Roto-Rooter’s adjusted EBITDA surged 27.1% to $65.8 million.

Chemed Corporation (NYSE:CHE) announced it will release its third-quarter financial results for the period ending September 30, 2021, on October 28, 2021, post-market close. A conference call to discuss these results will take place on October 29, 2021, at 10 a.m. ET. Participants can join the call using the toll-free dial-in number or access the live webcast on Chemed's website. Chemed operates two key subsidiaries: VITAS Healthcare, a leading hospice care provider, and Roto-Rooter, a top plumbing service provider.

Chemed Corporation (NYSE:CHE) has declared a quarterly cash dividend of 36 cents per share, marking a 5.9% increase from the previous 34-cent dividend. This dividend is payable on September 2, 2021, to shareholders on record as of August 16, 2021. This announcement highlights the company’s commitment to returning value to its shareholders, as it represents the 201st consecutive quarterly dividend in Chemed's 50-year history as a public company.

Chemed Corporation (NYSE: CHE) reported Q2 2021 results with revenue up 6.0% to $532 million. GAAP EPS fell 29.9% to $3.51, while adjusted EPS rose 4.3% to $4.60. VITAS saw a 4.7% revenue decline to $312 million, despite a slight increase in admissions. Roto-Rooter’s revenue soared 26.1% to $220 million, with a 40.1% increase in net income. Adjusted EBITDA for VITAS dropped 24.4%, while Roto-Rooter's adjusted EBITDA surged 37.2%. Chemed has $92 million in cash, no long-term debt, and plans to continue share repurchases.